Therapeutic Drug Monitoring (TDM) Sticker Project A New Method for Documenting Times of Medication Doses and Drug Levels.

Slides:



Advertisements
Similar presentations
Safe Medication Practice January 2011
Advertisements

Common/shared responsibilities between jobs.
Documentation.  Nurses are legally and ethically bound to keep patient information confidential  Nurses must work to protect patient records from unauthorized.
Clinical Pharmacokinetics Review Keith Christensen, Pharm D, BCPS Assistant Professor of Pharmacy Practice Pulmonary & Critical Care Medicine Creighton.
Setting: Wesley Medical Center, a tertiary-care referral center licensed for 760 beds with a 36-bed, level-III, NICU Study population: This study evaluated.
Medication Reconciliation
Hospital Pharmacy Part-2
Drug Utilization Review (DUR)
Medication Reconciliation Insert your hospital’s name here.
Fundamental Nursing Chapter 32 Oral Medications Inst.: Dr. Ashraf El - Jedi.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 9 Recording and Reporting.
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
10 Rights of Medication Administration
Medication History: Keeping our patients safe. How do we get all of the correct details?
Documentation PN 103. Introduction The “chart” = health care record – LEGAL record The process of adding written information to the chart is called: –
Medication Reconciliation : MSNU. Origins of Medication Reconciliation as a Patient Safety strategy The Institute for Healthcare Improvement (IHI) introduced.
Quality Improvement Prepeared By Dr: Manal Moussa.
Unit #7 - Basic Quality Control for the Clinical Laboratory
WHAT YOU NEED TO KNOW ABOUT 8 NORTH Orientation to Cardiology.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Practical Prescribing Session Berny Baretto (Antibiotic Pharmacist) 30 th August 2012.
Recommended by the Sentinel Event Alert Advisory Group NATIONAL PATIENT SAFETY GOALS FY 2009.
Chapter Quality Network (CQN) Asthma Pilot Project Team Progress Presentation Oregon Oregon Hillsboro Pediatric Clinic, LLC Hillsboro Pediatric Clinic,
Inpatient Pharmacy Vivian Sinkaset, Pharm.D., BCPS Miramar Science Club Guest Speaker April 28, 2010.
Kara Jackson Clinical Pharmacy Technician Minneapolis, MN.
Australian Commission on Safety and Quality in Health Care
The Respiratory Asthma Protocol Process By Jennifer McComis.
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Responsibilities and Principles of Drug Administration
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
The Value of Medication Therapy Management Services.
‘Safer use of intravenous gentamicin for neonates’ how-to guide.
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Clinical Pharmacy Part 2
Introduction to Pharmacology. Nurse Practice Act Defines scope Role of the LPN.
Documentation of Care Provided Patient’s care - who should do it? WHY DOCUMENT? When should it occur? Where should it be documented? How should it be documented?
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Practical Antibiotic Prescribing & Antibiotic Awareness Berny Baretto (Antibiotic Pharmacist) 21st November 2013.
On the CUSP: STOP BSI Improving Situational Awareness by Conducting a Morning Briefing.
Introduction In 2005, comparisons were made internally by word of mouth and externally with other Tenet Healthcare Corporation hospitals, Georgia Hospitals.
TDM Therapeutic Drug Monitoring
Copyright © 2008 Thomson Delmar Learning Interpreting Drug Orders Chapter 7.
Therapeutic drug Monitoring
EPMA- Learning from Serious Incidents STAT dosing Iain Davidson Chief Pharmacist Feb 16.
Continuous Infusion Vancomycin Pharmacist Education.
1 Second semester Chapter 32 Oral Medications Bader A. EL Safadi BSN, MSc Fundamental of Nursing – B Oral Medications.
Pharmacokinetics: Digoxin Allie Punke
Pharmacokinetic Questions
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
JUST GIVE IT: a 2 phase study to audit the Immediate Management of Patients with Proven or Suspected Neutropenic Sepsis by Ally Gruber Acute Oncology Clinical.
ICU Prescribing Made Easy 2015 Quick Guide to Safe Prescribing on Commonly Seen Drugs.
Pharmacist Impact on Patient Mortality and Advanced Cardiac Life Support Guideline Compliance During In-Hospital Cardiac Arrest Joseph Cavanaugh, PharmD.
Unit #6 - Basic Quality Control for the Clinical Laboratory
Allie punke pharmcokinetics Allie punke
The aminoglycoside antibiotics
Medication Reconciliation ROP Compliance
Introduction to Clinical Pharmacy
Planned Implementation Date: June 18, 2013
Warfarin Prescribing.
Clinical Pharmacokinetics
Fundamental Nursing Chapter 32 Oral Medications
Allie Punke Pharmacokinetics Allie Punke
Gentamicin – principles of use and monitoring
Interpreting Drug Orders
Principles and Methods of Drug Administration
Presentation transcript:

Therapeutic Drug Monitoring (TDM) Sticker Project A New Method for Documenting Times of Medication Doses and Drug Levels

Goals and Objectives Primary objective  To implement a system to encourage complete and accurate documentation of dose / level information at the bedside to allow for an accurate assessment of antibiotic levels for optimization of antibiotic treatment Secondary objective  To reduce the need for repeating antibiotic levels, to minimize…  Delayed attainment of therapeutic levels of drug  Delayed attainment of safe levels of drug  Discomfort to patient  Increased cost associated with levels

TDM Stickers Therapeutic Drug Monitoring (TDM) Record Med: Vancomycin Gentamicin Tobramycin Amikacin Other: ____ Dose: ____ Frequency: q6h q8h q12h q24h Other: ____ Date / precise time of preceding dose; Date: ____ Time: ____ Date / precise time of serum concentration; Date: ____ Time: ____

Why are we doing this??? Real life case #1 –A 13 year old boy with CF is being treated with tobramycin. A tobramycin peak and trough are ordered with the 4 th dose due at The antibiotic is timed at 0000, 0800, The 1600 dose is not charted. The tobramycin trough = 2.8 mcg/ml (goal < 2 mcg/ml) and peak = 14.2 mcg/ml (goal 10-14). The timing documented in the computer for the trough and peak are both reported as Of note, it is now 1100, and today’s 0800 dose has not yet been given. –Assessment: Cannot accurately assess the levels… Was the 2 nd dose given??? If yes, at what time??? Were the trough and peak drawn at the right times, at the end of the interval and 1 hour post-dose, respectively??? –Plan: Recommend repeating tobramycin peak and trough levels –Implications Potential delayed optimization of treatment… safety and effectiveness Potential increase discomfort to patient… peripheral venipuncture Increase cost… repeat levels

The Health-Care Team and The TDM Sticker Project Physicians NursesPharmacists The success of this program is dependent upon the active involvement of all professionals involved in the process of monitoring drug levels

TDM Sticker Project – Procedures Physician orders antibiotic requiring monitoring of drug levels Physician orders drug levels Nurse processes order for drug level and clips sticker(s) to nurses notes Nurse administers dose preceding TROUGH level and documents precise time of dose on sticker, then adheres sticker in nurses notes section of patient bedside chart Nurse draws trough level and documents precise time level drawn on sticker Nurse draws peak level and documents precise time level drawn on sticker Nurse administers dose preceding PEAK level and documents precise time of dose on sticker, then adheres sticker in nurses notes section of patient bedside chart Pharmacist assesses level(s) and makes recommendation regarding dose modification

TDM Sticker: Commonly Asked Questions What antibiotics do I need to use the sticker for??? The sticker should be used whenever levels are ordered for vancomycin, gentamicin, tobramycin, and amikacin

Where do I place the sticker in the patient’s chart??? TDM Sticker: Commonly Asked Questions To keep things easy, the sticker should be placed where you normally document your notes, in the nursing notes section of the patient bedside.

What if there is no room in the nurse’s notes section??? TDM Sticker: Commonly Asked Questions In that case, you can add a new progress notes sheet to your nurses notes and place it there.

How do I fill out the sticker??? TDM Sticker: Commonly Asked Questions It’s easy. Just circle the medication, fill in the dose, circle the frequency, and write in the precise time you gave the dose before the level was drawn, and then the precise time you drew the level. We’ll do an example in just a few minutes.

What does “precise time” mean for dose and serum concentration??? TDM Sticker: Commonly Asked Questions Good question. This is important. The precise times should be exactly when the dose was started or the level was taken. If the dose was given on a previous shift, this information may need to be obtained during sign-out.

Do I need to fill out two stickers if I am checking a peak and a trough??? TDM Sticker: Commonly Asked Questions Yes. When only a trough is ordered, such as for vancomycin, only one sticker is needed. But, when both a peak and trough are ordered, such as for the aminoglycosides; gentamicin, tobramycin, & amikacin, two stickers must be used.

TDM Sticker Examples Therapeutic Drug Monitoring (TDM) Record Med: Vancomycin Gentamicin Tobramycin Amikacin Other: ____ Dose: ____ Frequency: q6h q8h q12h q24h Other: ____ Date / precise time of preceding dose; Date: ______ Time: ____ Date / precise time of serum concentration; Date: ______ Time: ____ So my patient is being treated with vancomycin 100mg IV q6h and has a trough ordered with the 4 th dose. The 3 rd dose was scheduled to be given at 0800, but I gave it at I drew the level at This is how I am going to fill out the sticker…

Therapeutic Drug Monitoring (TDM) Record Med (Circle): Vancomycin Gentamicin Tobramycin Amikacin Dose: _25__ mg Frequency (Circle): q6h q8h q12h q24h Date / precise time of preceding dose; Date: Time: 0810 Date / precise time of serum concentration; Date: Time: 1605 Therapeutic Drug Monitoring (TDM) Record Med: Vancomycin Gentamicin Tobramycin Amikacin Other: ____ Dose: ____ Frequency: q6h q8h q12h q24h Other: ____ Date / precise time of preceding dose; Date: ______ Time: ____ Date / precise time of serum concentration; Date: ______ Time: ____ Therapeutic Drug Monitoring (TDM) Record Med (Circle): Vancomycin Gentamicin Tobramycin Amikacin Dose: _25__ mg Frequency (Circle): q6h q8h q12h q24h Date / precise time of preceding dose; Date: Time: 0810 Date / precise time of serum concentration; Date: Time: 1605 Therapeutic Drug Monitoring (TDM) Record Med: Vancomycin Gentamicin Tobramycin Amikacin Other: ____ Dose: ____ Frequency: q6h q8h q12h q24h Other: ____ Date / precise time of preceding dose; Date: ______ Time: ____ Date / precise time of serum concentration; Date: ______ Time: ____ So my patient is being treated with gentamicin 25mg IV q8h and has a peak and trough ordered with the 3 rd dose. The 2 rd dose was scheduled to be given at 0800, but I gave it at I drew the trough level at The 3 rd dose was scheduled to be given at 1600, but I gave it at The peak level was due at 1710, but I actually drew it at This is how I am going to fill out the sticker…

Efficacy of a TDM Sticker Protocol on V7 Pilot study –Site: Variety 7 –Design: Open, case-control study –Inclusion: All patients requiring vancomycin, gentamicin, tobramycin, or amikacin levels, who were admitted to V7 during 1/1/2006 – 12/31/2006 Patients were identified by a clinical pharmacist rounding on V7 –Patient demographics Aminoglycoside: n = 11 patients (18 sets of levels) Vancomycin: n = 5 patients (6 sets of levels)

Results Use of the sticker appeared to increase the % of drug levels that could be accurately assessed Improvement = 67% for the monitoring of aminoglycoside levels Assessable Levels (n) 100% 33% 100% 36% 100% 50% 0% 100% Note: Time of dose and level documented via sticker indicated the trough level was drawn a mean 0.26 hours (range hours) later than standard documentation indicated

Results Use of the sticker allowed for better assessment of the drug level The calculated mean peak appeared to be lower in the sticker protocol group, while the calculated mean trough appeared to be similar between the two groups Calculated drug level (mg/L)

 Implementation of the therapeutic drug monitoring sticker project on a general pediatric floor appeared to result in…  Improved data collection verses traditional methods  A more accurate assessment of antibiotic levels for optimization of antibiotic treatment  A hypothesized decreased need for repeating levels Conclusions